In the last trading session, 1.27 million shares of the Solid Biosciences Inc (NASDAQ:SLDB) were traded, and its beta was 1.98. Most recently the company’s share price was $5.12, and it changed around -$0.47 or -8.41% from the last close, which brings the market valuation of the company to $390.75M. SLDB currently trades at a discount to its 52-week high of $15.05, offering almost -193.95% off that amount. The share price’s 52-week low was $2.88, which indicates that the current value has risen by an impressive 43.75% since then.
Solid Biosciences Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.08. If we narrow it down even further, the data shows that 0 out of 12 analysts rate the stock as a Sell; another 5 rate it as Overweight. Among the rest, 0 recommended SLDB as a Hold, whereas 7 deemed it a Buy, and 0 rated it as Underweight. Solid Biosciences Inc is expected to report earnings per share of -0.78 for the current quarter.
Solid Biosciences Inc (NASDAQ:SLDB) trade information
Instantly SLDB has showed a red trend with a performance of -8.41% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 5.89 on recent trading dayincreased the stock’s daily price by 13.07%. The company’s shares are currently up 28.00% year-to-date, but still down -8.24% over the last five days. On the other hand, Solid Biosciences Inc (NASDAQ:SLDB) is 54.22% up in the 30-day period.
The consensus price target as assigned by Wall Street analysts is $19, which translates to bulls needing to increase their stock price by 73.05% from its current value. Analyst projections state that SLDB is forecast to be at a low of $12 and a high of $20.
Forecasts for the next quarter put sales growth at 0.00%.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 32.21%. Solid Biosciences Inc earnings are expected to increase by 39.19% in 2025, but the outlook is positive 19.61% per year for the next five years.
SLDB Dividends
Solid Biosciences Inc’s next quarterly earnings report is expected to be released in April.
Vanguard Total Stock Market Index Fund and iShares Russell 2000 ETF were the top two Mutual Funds as of Sep 30, 2024 . The former held 854.68 shares worth $4.38 million, making up 1.12% of all outstanding shares. On the other hand, iShares Russell 2000 ETF held roughly 628.9 shares worth around $3.22 million, which represents about 0.82% of the total shares outstanding.
